Czech National Bank’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.5M Buy
35,816
+2,196
+7% +$276K 0.04% 379
2025
Q1
$4.6M Buy
33,620
+2,025
+6% +$277K 0.04% 356
2024
Q4
$4.83M Buy
31,595
+1,923
+6% +$294K 0.04% 337
2024
Q3
$5.75M Buy
29,672
+1,928
+7% +$374K 0.06% 295
2024
Q2
$6.43M Buy
27,744
+2,250
+9% +$522K 0.07% 249
2024
Q1
$5.5M Buy
25,494
+117
+0.5% +$25.2K 0.07% 266
2023
Q4
$6.57M Buy
25,377
+65
+0.3% +$16.8K 0.09% 216
2023
Q3
$6.51M Buy
25,312
+8,178
+48% +$2.1M 0.1% 197
2023
Q2
$4.88M Buy
17,134
+170
+1% +$48.4K 0.11% 182
2023
Q1
$4.72M Buy
16,964
+109
+0.6% +$30.3K 0.12% 183
2022
Q4
$4.67M Sell
16,855
-9
-0.1% -$2.49K 0.12% 180
2022
Q3
$4.5M Buy
+16,864
New +$4.5M 0.13% 166